Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
SURMOUNT-1 (tirzepatide) data SURMOUNT-1 (N=2,539) tested tirzepatide 5, 10, and 15 mg against placebo over 72 weeks, reporting 15.0%, 19.5%, and 20.9% mean weight loss at the three doses respectively [2]
NN : Were only at the beginning of whats possible with GLP-1 therapies
A long term commitment is not required
This timeframe allows providers to assess: Side effect severity Appetite changes Energy levels Overall tolerance If side effects are present but mild, staying at the starting dose longer often leads to improvement without sacrificing progress
US$ 24.87
US$ 25.85
US$ 20.40
US$ 29.47
US$ 21.55
